Carter-Wallace Felbatol Successor Is Part Of R&D Rebuilding Under Wild
Executive Summary
A successor to the anti-epileptic Felbatol is among the development projects for Carter-Wallace's healthcare unit following its acquisition by an investment firm run by former Warner-Lambert exec Anthony Wild.